Welcome to our dedicated page for Accolade news (Ticker: ACCD), a resource for investors and traders seeking the latest updates and insights on Accolade stock.
Accolade, Inc. (ACCD) delivers technology-powered healthcare solutions that combine virtual care with expert clinical navigation. This news hub provides investors and industry professionals with essential updates on the company’s strategic initiatives and market position.
Track official press releases, earnings announcements, and operational developments through our curated collection. Find timely information on healthcare partnerships, service expansions, and technology innovations that shape Accolade’s role in personalized care solutions.
Our repository includes updates across key business areas: financial results, leadership changes, clinical program enhancements, and regulatory milestones. Each entry is sourced directly from company communications to ensure accuracy and compliance.
Bookmark this page for streamlined access to ACCD’s evolving story in healthcare technology. Monitor how the company’s unique blend of digital tools and clinical expertise continues to redefine employer-sponsored and individual healthcare navigation.
Accolade, Inc. (NASDAQ: ACCD) reported fiscal third quarter 2023 revenue of $90.9 million, a 9% increase from $83.5 million in the same quarter last year. However, the company experienced a significant net loss of $39.9 million, compared to a net income of $22.5 million in fiscal Q3 2022, reflecting a 277% decline. Adjusted EBITDA improved by 14% to $(10.2 million, while adjusted gross profit rose 6% to $41.8 million. The company reaffirmed its 2024 revenue growth and Adjusted EBITDA targets, aiming for positive cash flow by fiscal 2025.
Accolade, Inc. (NASDAQ: ACCD) will engage in the 25th Annual Needham Growth Conference on January 11, 2023, hosting a fireside chat at 1:30 pm ET. The event will be accessible via a webcast and replay on their investor relations website. Accolade offers healthcare solutions that enhance the patient experience through personalized, data-driven services. The company boasts a consumer satisfaction rating exceeding 90%, reflecting its commitment to improving healthcare outcomes and lowering costs.
Accolade, Inc. (NASDAQ: ACCD) announced it will release its fiscal third quarter 2023 financial results on January 9, 2023, after market close. The company will host a conference call at 4:30 p.m. E.T. to review the results. Accolade provides healthcare solutions to millions, emphasizing a personalized and value-based approach that includes virtual primary care and expert medical opinions. The company consistently achieves consumer satisfaction ratings above 90%. For more details, visit their website.
Accolade, Inc. (Nasdaq: ACCD) is advocating for equitable healthcare as a Health Equity Impact Champion sponsor at HLTH 2022. The company has welcomed FOLX Health, an LGBTQIA+ affirming care provider, into its Trusted Partner Ecosystem, enhancing its offerings to over 11 million members. Accolade's Chief Medical Officer and Deloitte Managing Director discussed employers' roles in improving healthcare access. The Trusted Partner Ecosystem, now celebrating three years, integrates various health solutions, providing significant value to employers and improving healthcare experiences for marginalized communities.
Accolade, Inc. (NASDAQ: ACCD) reported fiscal Q2 2023 revenue of $87.6 million, marking a 20% increase from $73.3 million in Q2 2022.
The company achieved a net loss of $46.5 million, improved by 25% year-over-year.
Adjusted gross profit grew by 31% to $39.2 million with a margin of 44.7%.
Accolade raised its revenue guidance for fiscal 2023 and anticipates positive cash flow and Adjusted EBITDA in fiscal year 2025.
Accolade, Inc. (NASDAQ: ACCD) will release its fiscal Q2 2023 financial results on October 6, 2022, after market close. A conference call to discuss the results will occur at 4:30 p.m. E.T. on the same day. Accolade provides personalized healthcare solutions, serving over 600 employers and millions of members, combining virtual care, mental health support, and care navigation. The company boasts a consumer satisfaction rating exceeding 90%. For more details, visit accolade.com.
Accolade, Inc. (NASDAQ: ACCD) announced participation in two investor conferences on September 13, 2022. The Morgan Stanley 20th Annual Global Healthcare Conference will occur at 10:35am ET, followed by the Baird’s 2022 Global Healthcare Conference at 10:50am ET. The company focuses on enhancing healthcare experiences through virtual primary care, mental health support, and intelligent care navigation, boasting over 90% consumer satisfaction ratings. Webcasts and replays will be available on their investor relations site.
Accolade, Inc. (Nasdaq: ACCD) has appointed Kelli Burns as its new senior vice president and chief information security officer as of July 25, 2022. Burns, previously with Ernst & Young and Symetra Financial, brings extensive cybersecurity expertise. She will lead Accolade's information security strategy, enhancing data protection for its over 600 enterprise clients, including major employers and government entities. The move underscores Accolade's commitment to safeguarding customer information as part of its Personalized Healthcare mission.
Priority Health has launched PriorityGPS™, an integrated health navigation and advocacy solution, through a partnership with Accolade (Nasdaq: ACCD). This product targets self-funded large employers, aiming to simplify employee access to benefits. PriorityGPS offers a single point of contact for support, including appointment scheduling and coverage guidance. The collaboration enhances personalized healthcare and is designed to improve employee engagement while lowering costs. Priority Health continues to prioritize quality care for its members.
FAQ
What is the current stock price of Accolade (ACCD)?
What is the market cap of Accolade (ACCD)?
